Toggle Main Menu Toggle Search

Open Access padlockePrints

Investigation of multi-drug resistance 1 (MDR1) and cytochrome P4502C8 (CYP2C8) pharmacogenetics on outcome from treatment of advanced breast cancer using paclitaxel in a UK national trial of a weekly versus 3-weekly schedule.

Lookup NU author(s): Dr Jo Lee, Julieann Sludden, Professor Alan Boddy, Dr Mark Verrill

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Lee, J. S., Sludden, J., Ferrigan, L. M., Boddy, A. V., Verrill, M. W., Cameron, D.

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 29th Annual San Antonio Breast Symposium

Year of Conference: 2006

Number of Volumes: 1

Pages: S252 no. 5118

Publisher: Breast Cancer Research and Treatment, Springer Netherlands

URL: http://dx.doi.org/10.1007/s10549-006-5678-0

DOI: 10.1007/s10549-006-5678-0

Library holdings: Search Newcastle University Library for this item

Sponsor(s): San Antonio Cancer Institute, Baylor College of Medicine, Cancer Therapy and Research Center, The University of Texas

ISBN:


Actions

Find at Newcastle University icon    Link to this publication


Share